Articles tagged with Positron Emission Tomography
The study found that PET/CT imaging was effective in detecting new malignancy and precisely localizing disease extent in patients with suspected occult recurrent cancer. The imaging modality provided valuable information for treatment planning, potentially avoiding further invasive procedures.
High levels of radiation from thyroid treatment can trigger homeland security detectors, which are now more common with increased sensitivity. Hospitals should develop documentation guidelines for patients undergoing nuclear medicine procedures to minimize this risk.
A study using combined positron emission tomography and computed tomography may help detect early abnormalities in the arterial wall, potentially useful for early disease detection, prevention, and prognosis. Nuclear medicine could provide valuable information on plaque composition.
A recent study found that smoking produces major changes in the flow of endogenous opioids, matching changes in how smokers feel before and after smoking. This system is also stimulated by heroin and morphine, suggesting a promising road for further discovery.
The initiative will enroll 800 people across five years, including normal elderly, diagnosed AD patients, and mild cognitive disorder individuals. Researchers aim to develop a standard imaging method for clinical trials, improve imaging methods, and validate imaging data.
The study aims to develop new treatments and monitor their effectiveness by tracking cognitive changes associated with MCI and AD. Researchers will use neuroimaging, biological, and clinical information from over 800 participants to identify critical biomarkers that respond to treatments.
UC Davis researchers have created a PET scanner that can image tiny cancer growths in mice, allowing them to monitor tumor development over time. The system enables early detection of cancer transformation and could lead to more sensitive screening tests for cancer-fighting drugs.
PET scans improved detecting distant metastases with an accuracy of 85%, compared to 55% for current standard diagnostics. The technique also showed high accuracy in diagnosing locoregional disease, surpassing current practice by 24 percentage points.
Recent advances in brain imaging may allow early diagnosis of Alzheimer's and other dementias, as well as improved assessment of treatment effectiveness. Researchers have developed new PET technologies to visualize abnormal protein accumulations in the brain, which may help differentiate between Alzheimer's and other forms of dementia.
A laser-based microscopy technique has confirmed and redefined the controversial 'astrocyte-neuron lactate shuttle' hypothesis for brain energy metabolism. The study reveals that neurons and astrocytes interact to burn oxygen and glucose, with astrocytes providing lactate fuel after glucose is converted from the bloodstream.
Researchers discovered a correlation between FDG uptake in PET scans and degree of plaque inflammation in patients with moderate to high-grade carotid stenoses. The study's findings offer hope for improving stroke risk prediction and developing new plaque-stabilizing drugs.
A new study using combined PET/CT imaging has effectively diagnosed diabetes-related osteomyelitis of the foot. The technique provides a precise location of infection, enabling easier treatment strategy definition and improved patient outcomes.
Researchers use 18F-FDDNP-PET to measure tangles and plaques in brain, providing valuable information on disease status. The technique accurately separates AD patients from control subjects, offering opportunities for early diagnosis and monitoring treatment effects.
A new technique using hybrid scanners combines PET and CT to diagnose coronary artery disease, providing a precise picture of the heart's function. This method is more accurate than traditional diagnostic methods and may relieve patients from invasive procedures.
Researchers in Japan used PET to differentiate between infected and non-infected vascular grafts, confirming its accuracy in diagnosing graft infections. The study's findings suggest that PET studies can safely and specifically identify patients who need treatment for graft infection.
A new combined PET/CT scanner has shown significant improvement in tumor staging accuracy compared to traditional CT and PET imaging methods. The study involved 260 patients with various oncological diseases, yielding accurate staging results in 84% of cases.
This innovative approach enables visualization of immune system killer cells attacking tumors, providing insights into the immune response. Dr. Witte's collaboration with clinicians and scientists is paving the way for molecular imaging in clinical trials.
A study of 32 patients with suspected paraneoplastic neurological disorders found that PET imaging successfully identified relevant lesions undetectable by alternative methods. The results suggest that PET is an appropriate and promising tool for patients with undiagnosed paraneoplastic neurological disorders.
Researchers have successfully used PET imaging to detect dementia in macaque models. The study utilized the peripheral benzodiazepine receptor to identify macrophage activity, which is linked to neurodegeneration.
A new study supports the use of PET scans in early diagnosis of Alzheimer's disease, particularly in its early stages. The study identifies a new PET technique that can clearly identify brain connections altered by Alzheimer's, leading to higher accuracy in diagnosing the condition.
A study found that PET scans revealed significant abnormalities in 53 patients, including 30 cases with malignant or premalignant tumors unrelated to primary cancer. Follow-up was crucial to diagnose incidental findings, which were often asymptomatic.
A new imaging agent, Pittsburgh Compound B, provides a unique view of amyloid plaques in the living human brain. This breakthrough discovery may contribute to understanding how Alzheimer's disease begins and grows, as well as develop effective treatments.
A study found that individuals with panic disorder have reduced expression of the 5-HT1A receptor protein, which regulates serotonin synthesis and release. This reduction is associated with decreased function in brain areas critical for anxiety regulation.
Researchers found that cognitive behavioral therapy targets limbic and cortical regions in a distinct pattern from drug therapy, which changes chemical balance in the brain. The study suggests that brain scans may one day help doctors determine the most effective treatment for patients with depression.
Researchers found that whole-body PET/CT scans were accurate in determining tumor stage for 75% of patients, compared to 54% with whole-body MRI. The study concluded that FDG-PET/CT can be recommended as a first-line tool for whole-body tumor staging of different oncological diseases.
A new dynamic PET technique has been developed to provide more accurate diagnoses and improve patient comfort during PET scans. By combining a short initial scan with a longer static scan, doctors can gather valuable data about cancer tumors and treatment response.
Researchers found that PABA significantly improves the effects of chemotherapy drugs and radiation on cancer cells. Additionally, FES PET imaging can predict response to endocrine therapy in breast cancer patients by measuring regional target expression.
A new study reveals that PET scans can significantly improve the accuracy of predicting Alzheimer's disease progression in patients with early memory complaints. By analyzing brain metabolic patterns, doctors can better diagnose and intervene earlier, potentially delaying cognitive decline.
A study found that PET scans can detect activation of lymph nodes in HIV-infected individuals, suggesting potential targets for treatment. Researchers propose using PET scans to locate active nodes and target them with radiation or removal.
Researchers found that people with high blood pressure have reduced blood flow to the brain compared to those with normal blood pressure, leading to slightly worse scores on memory tests. This vascular remodeling may explain why some individuals experience subtle differences in mental tasks.
Researchers found distinct lymphoid tissue activation patterns in patients with acute, mid-stage, and late HIV-1 disease. PET scans showed predictable sequence of lymph node involvement, suggesting potential for treatment interruptions during active node removal.
A study published in The Journal of Nuclear Medicine found that 18F-FLT PET scans are more accurate than 18F-FDG PET scans in differentiating between cancerous and non-cancerous lung tumors. However, the researchers noted that 18F-FDG is still a reliable tool for staging tumors.
Researchers at UC Davis have developed an advanced PET scanner, MicroPET II, that can resolve a volume of one cubic millimeter, significantly improving detection of small cancer cells in experimental animals. The non-invasive imaging technology allows researchers to gain more information and use fewer animals in studies.
Researchers found that a combination of low-dose spiral CT and selective use of PET can effectively detect early-stage lung cancer in high-risk individuals. The study showed that lesions up to 5mm can be safely followed up after 12 months without major risks of progression.
A recent study has found that 18F-FDG PET scans are more accurate than CT scans in predicting post-therapy Hodgkin's disease relapse. The diagnostic accuracy of 18F-FDG PET was 92%, while CT results were only correct in 56% of cases.
A study by Dr. Pio and colleagues found that FLT-PET imaging outperforms FDG-PET in predicting tumor response to chemotherapy in breast cancer patients. The researchers compared the two imaging modalities in 11 newly diagnosed patients, taking scans before treatment began, after the first dose, and following the final cycle.
The microPET Focus offers significant improvements in image resolution and system sensitivity compared to its predecessor. The new design features reduced detector crystal cross-sections and gap sizes, resulting in improved spatial resolution and increased sensitivity.
FDHT PET detected 46 lesions, outperforming conventional methods, which identified 59. The agent rapidly absorbed in metastatic lesions indicating functioning androgen receptors. Notably, FDHT uptake reduced in patients starting testosterone therapy.
A study by Joanna Fowler and colleagues found significant reductions in MAO B activity in the heart, lungs, kidneys, and spleen of smokers compared to non-smokers, with reductions ranging from 33 to 46%. The findings suggest that smoking impacts peripheral organs and highlight the need for further examination of these consequences.
A study found that PET-CT scans were more accurate than PET scans alone in staging non-small cell lung cancer patients. The combined imaging technique correctly identified lung cancer with chest wall and vascular spread, downgrading tumor severity in 13.3% of cases.
Dr. Barry Siegel is being recognized for his pioneering work in nuclear medicine, including the use of positron emission tomography (PET) in cancer detection and tumor staging. With over 220 publications to his credit, Dr. Siegel's contributions have significantly impacted the field of nuclear medicine.
New technologies, such as robotics and GPS-guided therapy, are being integrated with imaging technology to enhance precision in minimally invasive procedures. These advancements aim to reduce human error and improve patient outcomes.
A study found whole body MR imaging detected skeletal metastases in 80% of patients, outperforming bone scans in predicting complications like fractures. MR imaging also provided additional information about primary tumors and soft tissue metastases.
A study published by the American College of Radiology found that PET scans had a sensitivity rate of 93% compared to 46% for CT scans. Additionally, PET scans offered advantages over CT scans in terms of cost savings due to lower radiation exposure. The researchers recommend using PET scans for staging patients with suspected cancer s...
Researchers identified a link between specific genetic mutations and increased risk of osteosarcoma, a type of bone cancer. They also developed a non-invasive method to measure thymidylate synthase inhibition using carbon-labeled thymidine PET scanning.
Researchers found that 11C-acetate PET scans were more sensitive than 18F-FDG PET scans in detecting recurrent prostate cancer. The study used 46 patients with detectable serum PSA, and the imaging procedures were conducted on the same day.
Researchers have made a groundbreaking discovery by detecting Parkinson's symptoms on brain scans of living patients. The study, led by Dr. Robert Y. Moore, found positive evidence of nerve cell degeneration in areas controlling attention and wakefulness using PET scans.
A study found that 11C-Choline PET scans were more sensitive in detecting pelvic lymph node tumors and accurately staged their development, with an overall accuracy of 93%. This technique shows promise as a safe, non-invasive method for prostate cancer patients
Researchers used functional magnetic resonance imaging (fMRI) to study the effects of antidepressant venlafaxine on clinically depressed patients. The study found that the drug produced robust alterations in the anterior cingulate area of the brain within two weeks, which may help predict treatment response.
A grading scale and simple visual analysis of 18F-FDG PET scans were used to predict cervical cancer patient outcomes, with high accuracy in survival prognoses. The test's reproducibility was demonstrated by independent observers' close scores and results.
The study found that whole-body 18F-FDG PET scanning resulted in a change in treatment plans for 55 patients, avoiding unnecessary irradiation and treatment costs. PET scans also detected previously undiagnosed distant metastases in some cases, sparing patients from futile radiation therapy.
Researchers at Johns Hopkins Medicine conducted a study on combined PET-CT for detecting ovarian cancer, finding that the combination showed high sensitivity (73.6%) and specificity (100%) rates. This improved detection accuracy compared to using PET scans alone.
A study of 16 patients with active multiple myeloma found that FDG PET scans accurately identified those at high risk, revealing disease spread outside the bone marrow. The scan also showed promise in identifying new disease sites for patients with relapsing disease, suggesting its potential as a complementary diagnostic tool.
Scientists have developed a new, non-invasive method to study neurochemistry and behavior in animal models of neurological and psychiatric diseases. The microPET technique allows researchers to measure dopamine receptor levels in living animals, providing insights into disease progression.
Researchers have developed a new diagnostic tool using PET scans to detect Alzheimer's disease more accurately. By analyzing brain activity, the scans can identify changes that occur before patients themselves may recognize problems.
A new study has identified a unique brain marker of 'vulnerability' that may explain why people who recover from major depression remain at risk for another episode. The finding could lead to more targeted treatments and help identify family members at risk before they experience a major depression.
Researchers at Washington University's Molecular Imaging Center are developing new applications for existing technologies like PET scans. They're also exploring new methods of molecular imaging using near-infrared fluorescence and bioluminescence probes to study protein-protein interactions, immune cells attacking tumors, and the cours...
Women with stage IIIb cervical cancer may benefit from different treatments depending on the spread of their disease, according to a new study. The research found that women whose cancer had not spread to lymph nodes had the highest survival rates, while those with upper chest lymph node involvement typically died within months.
A new study found that 18F-FDG PET scans accurately predict lymphoma treatment outcomes, especially after one cycle of chemotherapy. The test's sensitivity was higher after the first cycle, making it a better predictor of outcome and response to therapy.
A brain-imaging study found that obese individuals have enhanced metabolic activity in specific regions involved in sensory processing of food. This suggests a heightened sensitivity to food palatability, potentially driving overeating in obese individuals.